Wordt geladen...
Insulin Degrading Enzyme inhibition, a novel therapy for type 2 diabetes?
The Insulin Degrading Enzyme (IDE) has been identified as a type 2 diabetes and Alzheimer’s disease susceptibility gene though its physiological function remains unclear. Maianti et al. (2014) now propose that an IDE inhibitor may be a promising therapeutic strategy for type 2 diabetes.
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4144405/ https://ncbi.nlm.nih.gov/pubmed/25100059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmet.2014.07.016 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|